Obesity, fatty liver and liver cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 2, 2005, Pages 173-177

  Qian, Yan ^a   Fan, Jian Gao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Fatty liver; Liver neoplasms; Obesity

Indexed keywords

ALCOHOL; COPPER ZINC SUPEROXIDE DISMUTASE; ESTROGEN; GLUTATHIONE PEROXIDASE; INSULIN; LEPTIN; LEPTIN RECEPTOR; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE; SOMATOMEDIN B; SOMATOMEDIN C;

ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; BODY MASS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CHINA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; ENZYME ACTIVITY; FATTY LIVER; HUMAN; LIVER BIOPSY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; MEDLINE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY PREVENTION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; WEIGHT REDUCTION;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; COMORBIDITY; FATTY LIVER; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBESITY; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 20344402794     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Blum HE. Molecular therapy and prevention of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2003;2:11-22.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 2003;348:1625-1638.
3. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13-21.
4. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344-350.
5. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002;36:150-155.
6. Sohda T, Kamimura S, Iwata K, Shijo H, Okumura M. Immunohistochemical evidence of insulin-like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: relationship to fatty change in carcinoma cells. J Gastroenterol Hepatol 1997;12:224-228.
7. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002;26:1159-1164.
8. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 2001;61:5016-5023.
9. Huang QL, Zhang S, Lin JY. The expression of leptin and its receptor and their relationship to angiogenesis, growth and metastasis in HCC. Fujian Yi Ke Da Xue Xue Bao 2002;36:29-32.
10. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-1219.
11. Fan JG, Zhen MD. The relationship between obesity and liver diseases and treatment countermeasure. Zhong Hua Nei Ke Zha Zhi 2003;42:438-440.
12. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
13. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok As. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-1354.
14. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002;35:1485-1493.
15. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253-1257.
16. Cotrim HP, Parana R, Braga E, Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? Am J Gastroenterol 2000;95:3018-3019.
17. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001;51:127-131.
18. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002;37:154-160.
19. Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, et al. Hepatocellular carcinoma with nonalcoholic steatohepatitis. J Gastroenterol 2004;39:391-396.
20. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140.
21. Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 2004;10:S69-73.
22. Horie Y, Yamagishi Y, Kajihara M, Kato S, Ishii H. National survey of hepatocellular carcinoma in heavy drinkers in Japan. Alcohol Clin Exp Res 2003;27:32S-36S.
23. Bunout D. Nutritional and metabolic effects of alcoholism: their relationship with alcoholic liver disease. Nutrition 1999;15:583-589.
24. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002;35:635-638.
25. Karube H, Masuda H, Hayashi S, Ishii Y, Nemoto N. Fatty liver suppressed the angiogenesis in liver metastatic lesions. Hepatogastroenterology 2000;47:1541-1545.
26. Konno K, Ishida H, Sato M, Komatsuda T, Ishida J, Naganuma H, et al. Liver tumors in fatty liver: difficulty in ultrasonographic interpretation. Abdom Imaging 2001;26:487-491.
27. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001;21:71-80.